JAK2ex13InDel drives oncogenic transformation and is associated with chronic eosinophilic leukemia and polycythemia vera | Blood | American Society of Hematology
You do not currently have access to this content.
You do not currently have access to this content.
The advent of reduced-intensity conditioning regimens, improvements in graft-versus-host disease prophylaxis, and better supportive care have permitted inc
Key PointsAllogeneic hematopoietic cell transplant recipients are at risk of clinically significant viral infections due to lack of T-cell immunity.The mul
Key PointsThe safety and efficacy benefits of ide-cel were proportionate in young and older patients despite frailty and geriatric characteristics.Treatmen
In this issue of Blood, Frigault et al1 describe the first-in-human trial of anti-CD37 chimeric antigen receptor (CAR) T cells in patients with refractory
Blood | 144 | 11 | September 2024
In this issue of Blood Advances, Dadwal et al1 share the results of a phase 2 trial evaluating the safety of and response to posoleucel, an…
Although complete remission rates in adults with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) have improved over the last two decades, it is sti
In this issue of Blood Advances, Shapiro et al1 report the results of a retrospective study evaluating the use of a CD34+ selected stem cell boost…
In this issue of Blood Advances, El-Mansi et al1 communicate a novel mechanism important in the context of hemostasis and thrombosis related to the role of